loading page

Perceval Sutureless Valve-A limbo concept or a future trial
  • +2
  • Ajeet Bana,
  • Saurabh Jaiswal,
  • Vimal Yadav,
  • Mukta Tiwari,
  • Anuj Sangal
Ajeet Bana
Eternal Heart Care Centre and Research Institute

Corresponding Author:bana_ajeet@yahoo.co.in

Author Profile
Saurabh Jaiswal
Eternal Heart Care Centre and Research Institute
Author Profile
Vimal Yadav
Eternal Heart Care Centre and Research Institute
Author Profile
Mukta Tiwari
Eternal Heart Care Centre and Research Institute
Author Profile
Anuj Sangal
Eternal Heart Care Centre and Research Institute
Author Profile

Abstract

Objective Aortic stenosis has traditionally been addressed with surgical aortic valve replacement with a stented prosthesis. Several technologies have emerged as an alternative treatment method for aortic valve disease. Among them, Perceval Sutureless valve has been used in clinical practice for more than a decade. The aim of this study was to evaluate the results of Perceval Sutureless valve from single centre in Indian population. Method Between April 2018 to December 2021, 30 elective patients underwent aortic valve replacement with the Perceval Sutureless valve. 19 patients had isolated AVR and 11 patients underwent AVR + Coronary artery bypass grafting (CABG) with average grafts 2.1 ± 0.8. Majority of isolated AVR, 12 of 19, were done by minimally invasive approach. Result Mean age was 67.3 ± 13.8 and mean STS score was 2.7 ± 1.5. Mean aortic cross clamp time for isolated AVR and combined procedure were 42 ± 11 and 74 ± 23 respectively. There was no in-hospital mortality. 3 patients required ventilation for > 24 hours. New onset left bundle branch block occurred in 4 patients which recovered before discharge in 2 patients. The peak and mean valve gradients were satisfactory. None of implanted valve showed para-valvular leak. Conclusion SAVR using Perceval Sutureless valve is associated with excellent results and represent a safe and effective treatment option for patients with severe AS. This valve also facilitates MI approach and reduces aortic x-clamp and cardiopulmonary bypass time.